Thieme Launches New Open Access Journal Therapeutics NOW

Thieme is expanding its open access portfolio to promote evidence-based therapeutic development. Therapeutics NOW will publish significant work in fields such as gene therapy, immunotherapy, drug discovery, targeted delivery systems, and personalized medicine. The journal connects experts from academia, industry, and clinical practice worldwide, aiming to rapidly incorporate evidence-based research findings into patient care. Authors benefit from fast, professional and efficient peer review processes to publish and disseminate their research open access.

Therapeutics NOW brings together researchers from chemistry, biology, engineering, clinical science, and policy. This interdisciplinary scope reflects the complexity of modern healthcare and supports a systems-level understanding of therapeutic innovation. Each published article features a Research Significance Highlight, which enables readers to quickly assess its translational relevance.